Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 How a Biologics CDMO Adds Value to mAbs Development & Manufacturing Programs | Contract Pharma

What are you searching for?

Sign in
Infographics

How a Biologics CDMO Adds Value to mAbs Development & Manufacturing Programs

A look at a CDMO’s value throughout a monoclonal antibody (mAb) therapeutic's lifecycle.

Released By Scorpius BioManufacturing

The growing number of monoclonal antibodies (mAbs), and the maturation of their process development and manufacturing, have led to contract development and manufacturing organizations (CDMOs) playing an increasingly important role in expediting these programs’ path to commercialization. This infographic explores how an experienced biologics CDMO adds value throughout a mAb’s lifecycle.



 

Request more information from Scorpius BioManufacturing

Request more information from Scorpius BioManufacturing

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters